SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: dino who wrote (5965)12/6/1998 12:45:00 AM
From: Linda Kaplan  Respond to of 7041
 
That scores NOTHING for Vasomax. If it's approved, and that's uncertain, its label will end up with similar warnings after its been used by enough people for a percentage to die. Viagra's had huge sales, and a small number of deaths. Odds are that if Vasomax were used by the same number of people there'd be at least as many deaths. The problem is that I think very few people will use Vasomax even if it's approved, so there won't ever be a similar comparison.

Linda


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News